These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 18241279)

  • 1. Decreased production of semaphorin 3A in the lesional skin of atopic dermatitis.
    Tominaga M; Ogawa H; Takamori K
    Br J Dermatol; 2008 Apr; 158(4):842-4. PubMed ID: 18241279
    [No Abstract]   [Full Text] [Related]  

  • 2. Aberrant epidermal expression of semaphorin 3A and nerve growth factor in prurigo nodularis.
    Takada S; Kou K; Nagashima Y; Ikezawa Z; Aihara M
    J Dermatol; 2013 May; 40(5):404-6. PubMed ID: 23398122
    [No Abstract]   [Full Text] [Related]  

  • 3. Co-stimulation with interleukin-4 and tumor necrosis factor-α increases epidermal innervation accompanied by suppression of semaphorin 3A.
    Sakai T; Takahashi D; Nikaido K; Okauchi K; Mori N; Irie R; Hatano Y; Fujiwara S
    J Dermatol Sci; 2014 Oct; 76(1):69-71. PubMed ID: 25088775
    [No Abstract]   [Full Text] [Related]  

  • 4. Psoralen-ultraviolet A therapy alters epidermal Sema3A and NGF levels and modulates epidermal innervation in atopic dermatitis.
    Tominaga M; Tengara S; Kamo A; Ogawa H; Takamori K
    J Dermatol Sci; 2009 Jul; 55(1):40-6. PubMed ID: 19443185
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibitory effects of UV-based therapy on dry skin-inducible nerve growth in acetone-treated mice.
    Kamo A; Tominaga M; Tengara S; Ogawa H; Takamori K
    J Dermatol Sci; 2011 May; 62(2):91-7. PubMed ID: 21458246
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quantitative analysis of nerve growth factor (NGF) in the atopic dermatitis and psoriasis horny layer and effect of treatment on NGF in atopic dermatitis.
    Yamaguchi J; Aihara M; Kobayashi Y; Kambara T; Ikezawa Z
    J Dermatol Sci; 2009 Jan; 53(1):48-54. PubMed ID: 18922683
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of Neuropeptides, Neurotrophins, and Neurotransmitters in the Skin of Patients with Atopic Dermatitis and Psoriasis.
    Kubanov AA; Katunina OR; Chikin VV
    Bull Exp Biol Med; 2015 Jul; 159(3):318-22. PubMed ID: 26201903
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of tacrolimus ointment on the expression of substance P, nerve growth factor, and neurotrophin-3 in atopic dermatitis.
    Kim HO; Lee CH; Ahn HK; Park CW
    Int J Dermatol; 2009 Apr; 48(4):431-8. PubMed ID: 19335435
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enhanced production and secretion of glial cell line-derived neurotrophic factor and nerve growth factor from the skin in atopic dermatitis mouse model.
    Tokime K; Katoh-Semba R; Yamanaka K; Mizoguchi A; Mizutani H
    Arch Dermatol Res; 2008 Aug; 300(7):343-52. PubMed ID: 18443810
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modulation of semaphorin 3A expression by calcium concentration and histamine in human keratinocytes and fibroblasts.
    Fukamachi S; Bito T; Shiraishi N; Kobayashi M; Kabashima K; Nakamura M; Tokura Y
    J Dermatol Sci; 2011 Feb; 61(2):118-23. PubMed ID: 21176873
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A hypothetical mechanism of intraepidermal neurite formation in NC/Nga mice with atopic dermatitis.
    Tominaga M; Ozawa S; Ogawa H; Takamori K
    J Dermatol Sci; 2007 Jun; 46(3):199-210. PubMed ID: 17350228
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hydrogen sulfide modulates the expression of axon-guidance molecules in human keratinocytes.
    Moniaga CS; Kamata Y; Ogawa H; Suga Y; Tominaga M; Takamori K
    J Dermatol Sci; 2020 Mar; 97(3):232-235. PubMed ID: 32035842
    [No Abstract]   [Full Text] [Related]  

  • 13. Neurotropin inhibits the increase in intraepidermal nerve density in the acetone-treated dry-skin mouse model.
    Kamo A; Tominaga M; Taneda K; Ogawa H; Takamori K
    Clin Exp Dermatol; 2013 Aug; 38(6):665-8. PubMed ID: 23745989
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Altered cutaneous expression of beta-defensins in dogs with atopic dermatitis.
    van Damme CM; Willemse T; van Dijk A; Haagsman HP; Veldhuizen EJ
    Mol Immunol; 2009 Aug; 46(13):2449-55. PubMed ID: 19576634
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aberrant suprabasal P-cadherin expression in acanthotic but not psoriatic thickened epidermis.
    Wakita H; Yamamoto Y; Furukawa F
    Arch Dermatol Res; 2003 Apr; 295 Suppl 1():S71-4. PubMed ID: 12677438
    [No Abstract]   [Full Text] [Related]  

  • 16. Possible role of nerve growth factor and interleukin-18 in pathogenesis of eczematous lesions of atopic dermatitis.
    Shaker OG; El-Komy M; Tawfic SO; Zeidan N; Tomairek RH
    J Dermatol Sci; 2009 Feb; 53(2):153-4. PubMed ID: 18922682
    [No Abstract]   [Full Text] [Related]  

  • 17. Effect of the phosphodiesterase 4 inhibitor E6005 on nerve growth factor elevation in irritated skin of NC/Nga mice.
    Ishii N; Wakita H; Shirato M
    J Dermatol Sci; 2014 Dec; 76(3):263-4. PubMed ID: 25455141
    [No Abstract]   [Full Text] [Related]  

  • 18. Effects of a topically applied preparation of epidermal lipids on the stratum corneum barrier of atopic dogs.
    Piekutowska A; Pin D; Rème CA; Gatto H; Haftek M
    J Comp Pathol; 2008 May; 138(4):197-203. PubMed ID: 18374938
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Proliferative processes in the epidermis of patients with atopic dermatitis treated with thymodepressin.
    Sapuntsova SG; Mel'nikova NP; Deigin VI; Kozulin EA; Timoshin SS
    Bull Exp Biol Med; 2002 May; 133(5):488-90. PubMed ID: 12420069
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Skin and systemic pharmacokinetics of tacrolimus following topical application of tacrolimus ointment in adults with moderate to severe atopic dermatitis.
    Undre NA; Moloney FJ; Ahmadi S; Stevenson P; Murphy GM
    Br J Dermatol; 2009 Mar; 160(3):665-9. PubMed ID: 19076975
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.